Glaxosmithkline Pharmaceuticals Limited, a active public limited company, was established on 13 November 1924 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1924PLC001151. Registered under ROC Roc Mumbai. it is listed on BSE: 500660 and NSE: GLAXO. It has an authorized capital of ₹180.00 Cr and a paid-up capital of ₹169.41 Cr.
Formerly known as British Drug Houses (India) Private Limited, British Drug Houses (India) Limited. It upholds a compliant status. In 2024, it reported revenue of ₹3,530.73 Cr and a net worth of ₹1,784.09 Cr. Employing 505 professional, Its leadership includes Subesh Ronald Williams (Director), Renu Sud Karnad (Director), Bhushan Arun Akshikar (Managing Director). Past directors included Anami Narayan Prema Roy, Simon Harford, Thyagarajan Venkatraman. It holds ₹21.87 Cr open charges and ₹130.00 Cr settled loans. Its latest AGM occurred on 27 June 2025, with the balance sheet filed on 31 March 2025. It is based at Gsk House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030.
L24239MH1924PLC001151
001151
13 November 1924
₹180.00 Cr
₹169.41 Cr
Roc Mumbai
Listed (BSE: 500660, NSE: GLAXO)
Active
Explore comprehensive insights into Glaxosmithkline Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subesh Ronald Williams | Director | 07 Apr 2017 | Current |
| Renu Sud Karnad | Director | 01 Apr 2019 | Current |
| Bhushan Arun Akshikar | Managing Director | 01 Dec 2022 | Current |
| Manu Anand | Director | 16 May 2022 | Current |
| Anup Wadhawan | Director | 26 Mar 2025 | Current |
| Juby Chandy | Cfo | 01 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Mar 2020 | Past |
| Pramod Abcsdd | Director | 18 May 2015 | Past |
| Pramod Abcsdd | Director | 31 Oct 2015 | Past |
| Pramod Abcsdd | Director | 01 May 2011 | Past |
| Pramod Abcsdd | Whole-Time Director | 27 Jan 2021 | Past |
| Pramod Abcsdd | Director | 29 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glaxosmithkline Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.42% increase. The company also saw a slight decrease in profitability, with a 3.79% decrease in profit. The company's net worth moved up by a moderate rise of 1.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Glaxosmithkline Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹218,700,000.00
₹1,300,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 1989 | The Hongkong And Shanghai Banking Corporation Ltd. | ₹21.87 Cr | Open |
| 20 Sep 2004 | Uti Bank Ltd. | ₹130.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Glaxosmithkline Pharmaceuticals has a workforce of 505 employees as of Dec 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Glaxosmithkline Pharmaceuticals Limited last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records. was recorded as a recent event.
Glaxosmithkline Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Anup Wadhawan was appointed as a Director was appointed as a Director on 26 Mar 2025 & has been associated with this company since 8 months . was completed.
Somasundaram Palamadairamaswamy was appointed as a Director was appointed as a Director on 26 Mar 2025 & has been associated with this company since 8 months . was recorded as a recent event.
Progress on Bhushan Arun Akshikar was appointed as a Managing Director was appointed as a Managing Director on 01 Dec 2022 & has been associated with this company since 2 years 11 months . was documented.
The activity Manu Anand was appointed as a Director was appointed as a Director on 16 May 2022 & has been associated with this company since 3 years 6 months . was completed.
The CIN of Glaxosmithkline Pharmaceuticals Limited is L24239MH1924PLC001151.
Glaxosmithkline Pharmaceuticals Limited is headquartered at Gsk House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030.
Glaxosmithkline Pharmaceuticals Limited was incorporated on 13 November 1924.
The current directors of Glaxosmithkline Pharmaceuticals Limited are
The primary industry of Glaxosmithkline Pharmaceuticals Limited is Manufacturing.
Glaxosmithkline Pharmaceuticals Limited is listed. It is listed on BSE: 500660 and NSE: GLAXO.
The authorized capital of Glaxosmithkline Pharmaceuticals Limited is ₹180.00 Cr, and the paid-up capital is ₹169.41 Cr.
The compliance status of Glaxosmithkline Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX